Home › Melanoma › Georgia › Atlanta
Pag-aaral pangklinika para sa Melanoma sa Atlanta, GA
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Winship Cancer Institute of Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Atlanta VA Medical Center, Decatur · 6 mi ang layo
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
- Piedmont Cancer Institute, Atlanta
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
- Emory University - Winship Cancer Institute, Atlanta
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Nagre-recruitPhase 1/2
- Emory University, Atlanta
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
- Winship Cancer Institute - Emory University, Atlanta
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 2
- USA10-0, Atlanta
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Piedmont Healthcare, Atlanta
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- Emory Winship Cancer Institute, Atlanta
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Northside Hospital, Atlanta
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Nagre-recruitPhase 3
- Winship Cancer Institute of Emory University, Atlanta
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Nagre-recruitPhase 3
- Winship Cancer Institute, Emory university, Atlanta
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 114, Atlanta
- Research Site 139, Atlanta
Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
Nagre-recruitPhase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Atlanta
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Nagre-recruit
- Emory University, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
Nagre-recruitPhase 1/2
- Emory - Winship Cancer Institute, Atlanta
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Emory University Hospital Midtown, Atlanta
- Emory University, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- at 2 pa
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- St. Louis, MO21 pag-aaral
- Durham, NC21 pag-aaral
- Salt Lake City, UT21 pag-aaral
Iba pang pag-aaral sa Atlanta
- Kanser (lahat ng uri)49 pag-aaral
- Non-Small Cell Lung Cancer47 pag-aaral
- Multiple Myeloma42 pag-aaral
- Kanser sa Suso41 pag-aaral
- Kanser sa Prostate33 pag-aaral
- Acute Myeloid Leukemia31 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Major Depressive Disorder25 pag-aaral
- Pagkabigo ng Puso25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.